Come learn about our upcoming collaboration system for labs and researchers in the field of adult stem cells - CLICK HERE
The Adult Stem Cell Research (ASCR) Network is an Internet-based project of The Cell Therapy Foundation designed to be a well-maintained and reliable source of information for the public regarding adult stem cell research, as well as to be a community of practice and collaboration among fellow researchers. ASCR publishes the latest scientific news in the adult stem cell arena, identifies the leading researchers in the field, and locates key clinical trials; as well as connects the global community of adult stem cell researchers with one another.
Tissue Genesis Applies CE Mark to Its Adult Stem Cell Isolation System Conformity Marking Allows Device to be Marketed Throughout Europe
HONOLULU, HAWAI‘I—Tissue Genesis, Inc., an innovator of advanced tissue engineering and cell therapy solutions, today announced that effective immediately, the Tissue Genesis Cell Isolation System will be available to the European marketplace.
The Tissue Genesis Cell Isolation System is a fully automated system that recovers potentially regenerative cells from a patient’s own fat in about an hour, with minimal operator intervention. No tissue pre-processing is required. The system accepts adipose (fat) tissue from the same device used for liposuctioning the tissue from the patient. The compact desktop unit readily fits into any clinical environment and uses preconfigured disposables for quick and easy assembly.
The company’s Tissue Genesis Cell Isolation System has successfully completed safety certification testing necessary to complete its declaration of conformity, allowing the company to apply the CE mark. “The application of the CE mark on our cell isolation system is an exciting milestone and presents a tremendous opportunity for Tissue Genesis, as it represents further advancement into the international commercialization of our products and technology,” said Anton C. Krucky, President and Chief Executive Officer of Tissue Genesis. “We look forward to continuing our research and development initiatives focused on applications that use a patient’s own therapeutic cells to address a range of medical concerns.”
Children’s Hospital of Pittsburgh of UPMC Study Demonstrates Unique Form of Bone Marrow Transplant Can Cure Sickle Cell Disease Results of study published in November issue of Biology of Blood and Marrow Transplantation
Pittsburgh, Pa. - November 7, 2008 -
A unique approach to bone marrow transplantation pioneered in part by a Children’s Hospital of Pittsburgh of UPMC physician has proven to be the only safe and effective cure for sickle cell disease, according to a new study.
Lakshmanan Krishnamurti, MD, a pediatric hematologist/oncologist at Children’s Hospital, helped pioneer a form of bone marrow transplantation which relies on reduced-intensity conditioning (RIC). RIC regimens are less toxic to patients and therefore can be offered to patients with severe sickle cell disease because they eliminate life-threatening side effects generally associated with bone marrow transplantation.
Yerkes Researchers Find Stem Cells From Monkey Teeth Can Stimulate Growth And Generation Of Brain Cells
Rhesus monkey dental stem cells show the ability to produce different types of cells, illustrating the potential for cell therapy and regenerative medicine.
ATLANTA — Researchers at the Yerkes National Primate Research Center, Emory University, have discovered dental pulp stem cells can stimulate growth and generation of several types of neural cells. Findings from this study, available in October issue of the journal Stem Cells, suggest dental pulp stem cells show promise for use in cell therapy and regenerative medicine, particularly therapies associated with the central nervous system.
Stem Cells with Potential to Regenerate Injured Liver Tissue Identified by Penn Researchers
PHILADELPHIA – A novel protein marker has been found that identifies rare adult liver stem cells, whose ability to regenerate injured liver tissue has the potential for cell-replacement therapy. For the first time, researchers at the University of Pennsylvania School of Medicine led by Linda Greenbaum, MD, Assistant Professor of Medicine in the Division of Gastroenterology, have demonstrated that cells expressing the marker can differentiate into both liver cells and cells that line the bile duct.
The Stem Cell Research Center (SCRC) is a center of excellence dedicated to the application of musculoskeletal research focused on the development of...
The Cardiovascular Research Institute (CRI) is the largest division of the MedStar Research Institute and focuses most of its translational and clinical research...
Our mission is to advance the current understanding of the use of stem cells in the treatment of patients with cardiovascular disease. The primary goal...
